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INTRODUCTION
The impetus for provider payment reform in healthcare
grew out of the recognition that growth in healthcare
spending in the United States has been unsustainable and
that despite this, the United States has not achieved better
health for its population when compared to other
developed nations. 1 Numerous factors have been
identified as potentially contributing to burgeoning
healthcare spending, including inadequate primary care
and avoidable complications of care. 2 Among these
factors targeted for reform was the fee-for-service
payment structure in healthcare which was thought to
incentivize more care rather than better care.3-4 In this
context, the Affordable Care Act (ACA) was passed in
2010 not only to expand access to care, but also to
redirect Centers for Medicare and Medicaid (CMS)
reimbursements for healthcare services and to address
the growing demand to curb healthcare spending by
rewarding value over volume. Following the ACA, the
Medicare Access and CHIP Reauthorization Act (MACRA)
was passed in 2015 to repeal the Sustainable Growth Rate
formula and to expand the scope of value-based payment
structures in healthcare.5

The ACA implemented four programs that addressed
provider payment reform: the Hospital Readmissions
Reduction Program (HRRP), the Hospital Acquired Condition
Reduction Program (HAC), the Value Based Purchasing
Program (VBPP) and the Value Modifier Program (VM).
HRRP applies a financial penalty to hospitals for 30-day
readmission rates that exceed national averages for specific
conditions such as heart failure and pneumonia. Upon its
inception, many within the healthcare industry expressed
concern that by design HRRP may unfairly penalize safety
net hospitals that care for a greater proportion of
low-income and low-literacy patients who are at a higher
risk for readmission. However, early studies have shown
that low-performing hospitals and specifically
low-performing safety net hospitals have reduced their
readmission rates proportionately more since program
implementation, reducing disparities between hospitals.6-7
HAC expands on the Hospital Acquired Conditions Initiative
which withheld incremental payment for eight hospital
acquired conditions and was found to be associated with
reduced rates of central line-associated bloodstream
infections (CLABSIs) and catheter-associated urinary tract
infections (CAUTIs).8 HAC builds on the progress made by
this program by applying an additional financial penalty to
hospitals ranking in the bottom quartile for rates of hospital
acquired conditions. VBPP quantifies high quality care
based on five domains: processes of care, clinical outcomes,
patient experience of care, patient safety, and cost of care.
These metrics are compiled into a total performance score
based on which hospital reimbursements are adjusted up
or down. This program aligned incentives with the existing
Physician Quality Reporting System (PQRS) for reporting
quality metrics, increasing transparency and public
availability of data through mediums like Hospital Compare.9
MACRA subsequently created two pathways for provider
reimbursement: the Merit Based Incentive Payment System
(MIPS) and Alternative Payment Models (APMs). MIPS is
rooted in the traditional fee-for-service payment structure
and consolidates several previously existing programs
including the Value Modifier Program. MIPS quantifies value
based on a weighted performance score that includes
quality of care, resource utilization, meaningful use of
electronic health records and clinical practice improvement.
Providers will receive bonuses or penalties ranging from
4% in 2019 to 9% in 2022 based on performance. APMs are
payment models that in order to qualify under MACRA
require providers to bear more than nominal financial risk.

The Medicine Forum, Volume 18 | 51 5

In 2015, Medicare set the goal that by the end of 2018, 90%
of fee-for-service payments would be tied to quality or
value and 50% of payments would be tied to quality or
value through alternative payment models.10
The environment in healthcare is changing, and this brings
with it serious challenges but also exciting opportunities to
improve the way physicians practice medicine. The
following is a transcript of our experts as they discuss the
effect of provider payment reform on clinical practice as
well as strategies for continuing to provide effective patient
care in a changing healthcare environment.

TRANSCRIPT

main person interacting with the patient. The
reimbursement models are shifting to support the team to
be an integral part of that. We have a care coordinator
now in our practice, and one of my patients said it best:
“Well I can never get you on the phone but I can always
get Paula on the phone. She knows what’s going on and I
know she can get you on the phone.” And it’s not just that
they can be accessible but they bring expertise that I don’t
have on community resources, on how to get patients
plugged in with visiting nurses, with food resources that
they need. In my experience, that’s been one of the
biggest changes that I have seen.

Dr. Kane: I’ll go ahead and jump in first. A core way that
I’ve seen this is through the transparency of our data
recording and I’m just going to use Primary Care as a
stepping stone here—Dr. Powell and Dr. Ward may be able
to amplify what I’m about to comment on. Our providers
in our Primary Care practices now know where they rank
in terms of vaccination rates, colon cancer screening
rates, mammography rates—things that are really of
intrinsic value to healthcare and to our population. What I
think we need to ultimately do, Neha, is move towards
true effective payments for the physicians who are really
doing an exemplary job meeting those goals. We’re very
fortunate that we’ve got a superlative faculty in Internal
Medicine who are taking great care of patients, but my bet
is that if you ask a doctor on the street, “How much is this
making a difference in your annual salary, in your
day-to-day life?” they may not think it necessarily has that
big of an impact in terms of tangible outcomes. We need
to continue to move in that direction because if we’re
going to be ready by 2018 to have that large of our
revenue based on quality, we’ve really got to be
incentivizing our physicians to move at that level. But the
good news is our faculty is well-aware of the quality
imperative. They have the availably of data for their own
practices and we’re beginning to build on this incrementally.
I would say to you I’m frustrated that we’re moving too
slowly and as an organization, we have to really accelerate
our pace of change.

Dr. Sorokin: I’m going to take the inpatient part which is
the part that I know well. Since the Affordable Care Act,
we’ve had an increased proportion of our payments be
subject to penalty. At the moment it’s 6%--a 6% withhold.
If you think about what the margin is for non-profit
hospitals, they generally run 1-4%. More than your margin
is being withheld by Medicare. So how does that change
the work that we’re doing? What’s happened on the
inpatient side is that there’s also a much stronger team
and multidisciplinary process to treatment. Take, for
example, the hospital-associated infections. There are six
that occur both in the value-based purchasing program
and the hospital-associated conditions program. If you’d
like to know what top decile performance is across the
country, it is zero. That gives you a sense of what’s been
happening nationally. We have working groups and most
of you are familiar with the fact that we have very standard
protocols for line infections. In fact, we have had quite a
good rate of central line infections—a 75% drop—similar to
rates across the country and that’s true across the country
and that tells you how fast people are improving the care
that they deliver. We have had dramatic drops over the last
few years in our rates of CAUTIs. We have plenty of work
to do for C.diff and you know that we’re doing huddles
now and we appreciate your support. Each one of those
has a network of doctors and nurses co-leading teams to
think through how to improve our processes so that as a
group, as an institution, we deliver more reliable care to
patients. I’d say that’s a fairly large change in how we
approach our work, and that’s a direct outgrowth of us
thinking differently about what it means to take care of a
patient. Is it really one person taking care of the patient, or
is it really the institution and the quality of the processes
we provide from intake in the Emergency Room or Direct
Admission on to discharge and potential readmission?
That’s a large feat.

Dr. Powell: I can speak to my experience, my [institutional]
memory is a little bit shorter. I’ve been at Jefferson now
almost five years, practicing here post-Affordable Care
Act, and I practice largely in the outpatient setting in
Primary Care. I think the biggest difference I’ve seen
evolving and continuing to evolve is the role of the team
in providing care as opposed to the physician being the

Dr. Ward: I think one of the things that I’ve seen in the last
five years at an institutional level—not just at Jefferson, but
across the country—is a different appreciation for primary
care involvement the community, a different way of
thinking in terms of population. And this requires a different
approach. How do we draw people into primary care?
I think this is starting to affect and draw attention to

Neha: A lot of these programs are designed to incentivize
us as providers to improve the way we deliver care, to be
more effective at delivering evidence-based, high-value
care. How have you seen this play out over the past five
years? How have you seen this influence the way we
practice medicine?
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subspecialists. If we really want to change and influence
costs, procedures and things are really being done by
subspecialists. I’ve seen an appreciation for primary care
and the need for a team, as well as the need to train
people differently to operate as a leader of a team. This is
affecting residencies and fellowship programs. It’s hasn’t
changed yet in terms of compensation to get a stampede
of people going into primary care, but it’s already started
to affect primary care significantly and will affect subspecialties more. At Jefferson, we’ve seen the need to work
as a team with our family practice colleagues in the
outpatient setting and the hospital because we’re looking
at everything now. Care doesn’t stop when patients get
discharged from the hospital. It doesn’t stop when they
get admitted to the hospital. To improve cost and quality,
we have to look at the continuum.
Dr. Nash: First, I’m an avid reader of the Medicine Forum.
I can offer a bit of national perspective. Themes I heard
here: teamwork, care coordination, accountability, and
transparency. The paradox? For doctors, focusing of cost
and finance problems is never the way to fix cost and
finance problems. The only way to fix these challenges is
with the great answers we’ve heard here: teamwork,
transparency, care coordination, and accountability. No
one has ever measured what I’ve done as an outpatient
physician or given me non-punitive feedback on my
performance, but it will be these paradigm changes that
make it work.
Neha: A couple of you have mentioned this issue of
transparency, and I know people can now look up their
doctors online. What role has this played in the delivery of
patient care?
Dr. Kane: I think the first and traditional response that
physicians have to data is that the data is not correct. “My
patients in Center City, Philadelphia are much more
complicated.” We need to get beyond that and get to a
place where we’re embracing the data. At the same time,
there is a valid point in making sure that the data is
accurately corrected for complexity. I do know of some
sophisticated practices that have PR firms responsible for
wiping the data off the screen, flooding bad reviews with
positive reviews. But I think “hospital compare” will become
more of the norm, and we’re ready and excited for that.
We’re happy to use the data.
Dr. Nash: I concur. The search evidence about who uses
that information is actually not intuitive. Does anyone out
there besides us go to the website? Consumers are
incredibly confused about all of this. Most of them have
never heard of it. We can’t fool ourselves into thinking that
the public pays any attention to this at all. Their opinions
about individual doctors and hospitals stem from 1. Family,
2. Friends, and 3. What they read on the internet—and it’s
not CMS.gov. I think the severity adjustment is really

important. Hospitals like Jefferson do get penalized
because social determinants are messier with some of our
patients. Maybe they don’t have a place to go, maybe they
can’t afford their medications, maybe they don’t have a
ride to go back to the doctor. Most avid readers of the
report cards are the delivery systems themselves. It’s a
pretty competitive market, this town. So those are the
people who pay the most astute attention.
Dr. Sorokin: The other purpose of transparency is for
physicians themselves. It doesn’t even have to make it
public. Even internally, we have a pretty motivated crew of
caregivers who are driven to improve their own practice
of medicine with the appropriate feedback. To give you an
example, Pittsburgh chose to make HCAHPs data available
for each physician. They didn’t plan any interventions, they
just made the data available. And their numbers improved—
the physicians did it themselves. If you’ve never been
measured, you don’t know where you are.
Dr. Ward: If you’ve ever Googled yourself, HealthGrades
sometimes comes up and people have said they’ve found
me through that. I put a personal statement online, and
the majority of my patients tell me they were looking
through the website and one of the reasons they came to
me was based on my philosophy on medicine. I think
change is inevitable. I agree that a lot of the way we’ve
done it in the past has been with individual providers
noticing, “My practice is lower than yours in this metric,”
and that’s driven a lot of change. Quality improvement is
great—not by penalizing, not by incentivizing, but just by
putting people’s numbers up there. The pendulum of
medicine swings all the time; doctors are feeling
over-measured and wonder if that really does improve
care. Does a flu shot actually stop people from going into
the hospital or dying? We should be moving more towards
outcomes, but we can’t have too many outcomes if these
measurements are just making our lives miserable and not
really improving patient care. If we’re collecting data on
many things and nothing’s really useful, that’s where we’re
going to get pushback. We have to be careful about
selecting some outcomes that the doctors and their
teams can have some improvement over. We don’t have
that nailed down yet, but that’s what we need to work
towards.
Dr. Nash: That’s a great point, and in my business of “mea
culpa,” we lose sight of too many measures. They’re
calling this “measurement mania” We’re at risk of that.
You’re only going to improve what you measure, so you
better be careful about what you measure. Self-defeating
measurement mania is very real.
Neha: You mention measurement mania and I know
we’re in the middle of transitioning to a new inpatient
EMR. How can we use this EMR to identify measurements
that are meaningful?
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Dr. Ward: We can’t do this with chicken scratch and an
Excel spreadsheet. You need a system, and it’s one of the
reasons we invested in something like Epic, but Epic is not
great at this. This was my third installation of Epic at an
institution—I must have done something wrong in a
previous life. During my fellowship at Penn, one of my
co-fellows started a project that required data collection
from Epic, and it was so difficult that she changed her
topic on how difficult it was to get something out of Epic.
It’s amazing. But it’s partly because we haven’t been
pushing for it because it hasn’t really been impacting our
finances. It’s the dollar that drives this from a systems
standpoint. Then it changes our workflow and practices.
Honestly, it can’t be that doctors are doing all this stuff.
We’re not there yet, but eventually I’d want doctors to say,
“I haven’t ordered a mammogram in a year because my
team does it,” and the EMR can be used to make that
easier.
Dr. Sorokin: Go Epic. It’s the largest quality safety project
that we’ve undertaken. We will get better at this—not in the
first day, week, or month, but we will get better and how
to get data out and use the EMR to its full potential.
Ultimately, I’d like to get to a point where we could rely on
the EMR to, say, keep track of how long patients have had
central lines in for and when their dressings were last
changed. It would flag when a dressing was due to be
changed to reduce risk of oversight and subsequent
central line infections. That is the hope, to identify gaps in
patient care and predict potential complications in real
time, and there’s real promise with it.
Dr. Powell: The value of Epic is that it will make part of our
visits easier—like ordering mammograms, flu shots, and
diabetes screening—so we can spend time discussing
other things that may be harder to capture. Have I engaged
the family? Have I made sure that the patient understands
what’s going on? Have I addressed potential barriers to
care? That’s the value of this, to make some things easier
and quicker so we can spend more time on things really
important to patients and do more of the work that we
actually find fulfilling.
Dr. Nash: EMRs in general can be used as a predictive tool
because no one can predict patterns as easily, but
something a little closer at hand is its registry function.
Basic stuff like generic drug prices, screenings, HCAP
scores per physician—all of this will be happening before
predictive analysis and can still be pretty helpful by
providing good comparative information. Everyone here
was at least an A- student and is going to want to get
better. If feedback is provided in a non-punitive way, I think
we’ll see a stampede to improve.
Neha: What challenges have come up so far and what are
the biggest challenges moving forward—the next steps in
the pathway?
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Dr. Kane: Maybe I’ll start with the big picture here. We
spend 18% of our GDP on healthcare in the US. I can relate
that to the budget of my own house. I’ve got kids I want
to send to college, a mortgage I have to pay off, utilities,
retirement. If I have 18% that I have to allocate to healthcare,
I know I would have to squeeze out other essential
elements to survive and succeed and someday retire. If
you look at a traditional business model, a large fraction of
my dollars earned would be spent on health insurance for
my employees. We haven’t moved toward healthcare
reform and we have to do it quickly for businesses to
thrive and for communities to thrive here.
Dr. Nash: Let me see if I can give a similar, broader
perspective from the country’s point of view. I was at
Capitol Hill two days ago when the Republican Party
proposed its own healthcare bill. The punchline is—we are
only 20% of the story. Jefferson, HUP, Temple, Drexel,
we’re all just 20%. The other 80% is comprised of social
determinants, and those are often tough to handle in
settings like this. If you’re poor in the U.S., you’re screwed.
Tens of millions of people don’t have health insurance.
Twenty-five percent of people in Philadelphia smoke
cigarettes. Forty percent of kids in public schools are
obese. Poverty is the principal driver here. While we want
to be efficient and not focus on cost and finances and the
system, the punchline has very little to do with what goes
on in these four walls. Evidence-based facts (and not
alternative facts) are that countries that spend more on
these social determinants have better healthcare
outcomes. They are directly related.
Dr. Ward: I think it’s going to be about how we interact
with our community. Academic medical centers will have
to touch day-to-day lives; that’s one way it’ll affect us.
There’s a global budget at Hopkins, at the Mayo Clinic—
Here’s this much money, figure out how to make it work.
If you use less, you profit. If you use more, that’s on you.
It really warps, in a good way, how you approach medicine.
You may spend longer with the people who really need it,
and you might not invest in more doctors—but rather in
more care managers, social workers. We fought this tooth
and nail all the way, but it’s coming. We talk about HMOs
and capitation: each person is worth $8 for example. A
patient can see you 15 times that year and he’s still only
worth $8. It’s callous, and it’s not the way to run a
healthcare system, but you’ll want to advertise on the
second floor so you don’t see the people with wheelchairs
or the elderly. We’re going to be responsible for the
patient’s hospitalization and outpatient and skilled nursing
facility and homecare costs. If they leave us and go to
Penn, we’ll be responsible for the going-to-Penn costs.
How is that going to affect us? We’re going to have to start
looking at subspecialists. There’s been an increasing
microscope on how subspecialists are using dollars and
how it affects overall spending.

QUESTIONS
Dr. McKenzie: In an NPR interview, a congressman who is
actually an OB/GYN from a district in Kansas pointed out
what a disaster the Affordable Care Act has been for himself
and his patients. There is no access to care. But he said,
“People can always go to the emergency room.” If we’re
challenged with a large proportion of people who are
uninsured, how will our EDs survive?
Dr. Ward: Without getting too political here, there is a
difference between access to care and true healthcare. We
say we have the best healthcare in the world and people
can always go to the ED, but that is not true healthcare. The
ED is not equipped to take care of screenings or
management of chronic conditions. They’ll make sure
you’re not dying.
Dr. Kane: The ED physicians don’t want patients using the
ED as their primary care. If you look at Neha’s graph on
countries with the lowest healthcare spending, one of the
big differences between those countries and ours is that
those countries provide access to PCPs for a greater portion
of the day and the week. You can get to an acute care visit
the same day, in the evenings and on the weekends. Not in
the ED but in a primary care setting with a provider who
knows them and cares about them and deals with their
ongoing issues in a positive way.
Dr. Powell: The only reason we have access to the ED for
primary care issues is because of legislation. We’ve legally
made it such that EDs cannot turn any patients down, so
this becomes the primary site that uninsured patients with
multiple problems and nowhere to go turn. When we think
about how health reform moves forward, we have to think
about the structures that we’ve legally created and whether
or not they reflect our values.
Dr. Nash: We’d bankrupt the system and force it to close. I
think there’s a big structural issue. Every Western developed
country has three PCPs to one specialist and we’re just the
opposite. Temples of technology like us need to make an
important decision. If we really believe that more access
and more PCPs are the structural fix to this question, we
need to change the environment in which we’re largely
training subspecialists. You’ve got to call it when you see it.
That is a big issue.
Dr. Cohen: Is this going to lead to universal healthcare in
the U.S.?

create benefits to attract more people to their jobs. If you
came and worked, you got better healthcare. We’re not
going to change that on a dime, and our individualist
society is not going to allow us to create a single
government system for everybody. They say Americans
always figure out the right thing to do at the last minute
when there’s no other choice. I don’t see this coming for
the next several years.
Dr. Nash: I’d like to end on a positive note. First, how
awesome to have a forum like this. Nothing like this existed
certainly when I was a house officer. Secondly, we’re very
lucky on this campus to have a college devoted to studying
this very issue. If people are interested and want to learn
more, you don’t have to go anywhere. We’re right here. All
our work is right here. We’re fortunate to have an
organization that has made a commitment to look at these
issues, to teach and promote this. You have to look at this
as a glass half-full picture.
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Dr. Ward: The short answer, in my personal opinion, is that
universal healthcare is the only way to fix this—but it’s not
coming anytime soon and it may not be the right idea for
the U.S. There was a great article done in the Annals of
Internal Medicine looking at various countries and how
healthcare came to be because of the foundation
post-World War II. The U.S. got our system because, in
short, we couldn’t pay people more money so we had to
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